HbA1c: What It Means, % to mmol/mol Conversion & Diabetes Targets

HbA1c is the single most important number in diabetes management. It tells you what your blood sugar has averaged over the past 2–3 months — not just what it was when you fasted this morning. For a patient with diabetes, the HbA1c is the report card that determines whether current treatment is working, whether complications are likely to develop, and whether the medication needs to be changed.

Yet despite its importance, HbA1c is also one of the most misunderstood tests in clinical practice. Patients confuse % with mmol/mol. Clinicians apply a single target to every patient. And in India specifically, certain conditions — anaemia, haemoglobin variants, and G6PD deficiency — can make HbA1c falsely high or low, leading to incorrect clinical decisions.

This guide explains HbA1c from first principles, provides a full conversion table, clarifies diagnosis and treatment targets, and highlights the important limitations in the Indian population.

What Is HbA1c and What Does It Measure?

Haemoglobin A1c (HbA1c) is formed when glucose in the bloodstream attaches to haemoglobin — the oxygen-carrying protein inside red blood cells — in a process called glycation. The higher the blood glucose level, the more glycation occurs.

Because red blood cells live for approximately 120 days (about 3 months) before being broken down and replaced, the HbA1c reflects average blood glucose over this period. It is not affected by what you ate yesterday or whether you fasted before the test — making it far more clinically useful than a single fasting glucose measurement for monitoring long-term glycaemic control.

Technically: HbA1c is expressed as the percentage of haemoglobin that has glucose attached to it. An HbA1c of 7% means 7 out of every 100 haemoglobin molecules in the blood have glucose attached.

Two Units — % and mmol/mol — and How to Convert

There are two different ways HbA1c is reported, which causes considerable confusion:

DCCT/NGSP (%) — "old" units: Used in the USA, India, and many other countries. Reports HbA1c as a percentage (e.g. 7.0%). Named after the Diabetes Control and Complications Trial.
IFCC (mmol/mol) — "new" units: The internationally standardised unit adopted by the UK and Europe since 2009. Reports HbA1c in millimoles of glycated haemoglobin per mole of total haemoglobin (e.g. 53 mmol/mol).

Conversion Formulas

% to mmol/mol: (HbA1c % − 2.15) × 10.929
mmol/mol to %: (HbA1c mmol/mol ÷ 10.929) + 2.15

Example: HbA1c 7.0% → (7.0 − 2.15) × 10.929 = 4.85 × 10.929 = 53 mmol/mol

Quick Reference Conversion Table

5.0%

31 mmol/mol

Normal

5.5%

37 mmol/mol

Normal

5.7%

39 mmol/mol

Pre-DM

6.0%

42 mmol/mol

Pre-DM

6.4%

46 mmol/mol

Pre-DM

6.5%

48 mmol/mol

Diabetes

7.0%

53 mmol/mol

Target

7.5%

58 mmol/mol

High

8.0%

64 mmol/mol

High

9.0%

75 mmol/mol

Very High

10.0%

86 mmol/mol

Very High

12.0%

108 mmol/mol

Severe

🩸 Convert any HbA1c value between % and mmol/mol instantly: RxMedCalc HbA1c Converter →

HbA1c for Diagnosis of Diabetes and Prediabetes

HbA1c (%)	HbA1c (mmol/mol)	Diagnosis	Action
< 5.7%	< 39	Normal	Routine screening. Lifestyle advice.
5.7–6.4%	39–46	Prediabetes (IFG/IGT)	Intensive lifestyle intervention. Re-test annually. Consider metformin in high-risk patients.
≥ 6.5%	≥ 48	Diabetes mellitus	Confirm with repeat HbA1c or FBG on a different day (unless clearly symptomatic). Start management.

🇮🇳 Indian-specific note (RSSDI/ICMR): Indian guidelines recommend screening for diabetes using HbA1c from age 40 onwards (or earlier with risk factors: obesity, family history, GDM, hypertension). Given that Indians develop T2DM at a younger age and lower BMI than global averages, many experts recommend screening from age 30 in high-risk Indian individuals.

HbA1c Treatment Targets — Individualised, Not Universal

The most important concept in modern diabetes management is that HbA1c targets must be individualised. A single target of 7% for every patient is outdated and potentially harmful. The ADA 2024 and RSSDI guidelines provide a framework:

Patient Group	HbA1c Target (%)	HbA1c Target (mmol/mol)	Rationale
Most non-pregnant adults with T2DM	< 7.0%	< 53	Reduces microvascular complications. UKPDS/DCCT evidence base.
Young, recently diagnosed, no CVD	< 6.5%	< 48	Early intensive control provides long-term "legacy effect" (metabolic memory).
Elderly (> 70 yrs), frail, or multiple comorbidities	7.5–8.0%	58–64	Avoids hypoglycaemia risk in vulnerable patients. Quality of life priority.
Limited life expectancy / advanced complications	8.0–8.5%	64–69	Avoiding symptomatic hyperglycaemia. Avoiding hypoglycaemia. Palliative intent.
Pregnancy (pre-existing T1DM or T2DM)	< 6.5% if safe	< 48	Reduces foetal complications. Must balance against hypoglycaemia risk.
Gestational diabetes (GDM)	< 6.5%	< 48	Reduces macrosomia, perinatal complications.
T1DM (any age)	< 7.0%	< 53	DCCT-proven benefit. Continuous glucose monitoring increasingly used alongside HbA1c.

What HbA1c Tells You — and What It Doesn't

HbA1c reflects the average blood glucose over 2–3 months, weighted toward the most recent 4–6 weeks (because newer red cells are more glycated per unit of glucose exposure). However, two patients with identical HbA1c values may have very different glucose patterns:

Patient A: consistently moderate hyperglycaemia throughout the day → HbA1c 7.5%
Patient B: severe post-meal spikes alternating with hypoglycaemic dips → HbA1c also 7.5%

These patients have the same HbA1c but very different glycaemic profiles — Patient B has dangerous glucose variability that HbA1c completely misses. This is why continuous glucose monitoring (CGM) and Time in Range (TIR) are increasingly used alongside HbA1c in modern diabetes management, particularly in T1DM.

When HbA1c Is Unreliable — Critical for India

Several conditions cause HbA1c to be falsely high or falsely low. These are particularly relevant in India, where haemoglobin disorders and nutritional anaemia are common:

Conditions Causing Falsely LOW HbA1c (underestimates blood sugar)

Iron deficiency anaemia: Very common in Indian women. Accelerated red cell turnover with reticulocytosis lowers HbA1c by up to 1–2%. A diabetic patient with iron deficiency may appear well-controlled when they are not.
Haemolytic anaemia: G6PD deficiency, autoimmune haemolysis, malaria — reduced RBC lifespan means cells spend less time being glycated.
Recent blood transfusion: New donor red cells have not been glycated — falsely lowers HbA1c for 8–12 weeks.
Pregnancy: Expanded plasma volume and increased RBC turnover — HbA1c is consistently lower in pregnancy at any given glucose level.

Conditions Causing Falsely HIGH HbA1c (overestimates blood sugar)

Iron, B12, or folate deficiency without frank anaemia: Reduced RBC production with relatively older cells → more time for glycation.
Chronic kidney disease: Carbamylated haemoglobin can interfere with some HbA1c assays.
Haemoglobin variants (HbS, HbC, HbE, beta-thalassaemia trait): Depending on the assay method used, haemoglobin variants can cause spuriously high or low HbA1c readings. HPLC-based assays are more reliable than immunoassay methods for patients with known haemoglobinopathies.
Alcoholism, hypothyroidism: Associated with higher HbA1c at any given glucose level.

⚠️ In Indian patients with microcytic anaemia — check Mentzer Index and ferritin before relying on HbA1c alone. A diabetic woman with undiagnosed iron deficiency may have a falsely reassuring HbA1c. Use fructosamine or self-monitored blood glucose (SMBG) as alternatives when HbA1c reliability is in doubt.

Estimated Average Glucose (eAG) from HbA1c

HbA1c can be converted to an estimated average glucose (eAG) value expressed in mg/dL — which many patients find more intuitive than a percentage:

eAG Formula

eAG (mg/dL) = (28.7 × HbA1c %) − 46.7
Example: HbA1c 7.0% → (28.7 × 7) − 46.7 = 200.9 − 46.7 = 154 mg/dL average

Key Takeaways

HbA1c reflects average blood glucose over ~3 months — weighted toward the last 4–6 weeks
Two units: % (DCCT) used in India and USA; mmol/mol (IFCC) used in UK and Europe
Conversion: (% − 2.15) × 10.929 = mmol/mol. HbA1c 7% = 53 mmol/mol.
Diagnosis: ≥ 6.5% (48 mmol/mol) = diabetes; 5.7–6.4% = prediabetes
Standard treatment target: < 7.0% for most adults — but individualise for elderly (< 8%), young (< 6.5%), frail (< 8.5%)
HbA1c is unreliable in iron deficiency anaemia, haemolytic anaemia, haemoglobin variants, and pregnancy — all common in India
Use fructosamine or SMBG as alternatives when HbA1c reliability is questionable
HbA1c misses glucose variability — CGM and Time in Range complement it in T1DM and complex T2DM

References

American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1).
RSSDI (Research Society for Study of Diabetes in India). RSSDI Clinical Practice Recommendations for Management of Type 2 Diabetes Mellitus 2022. Int J Diabetes Dev Ctries. 2023.
Nathan DM et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478.
ICMR. ICMR Guidelines for Management of Type 2 Diabetes. 2018.
Sacks DB et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2023.

This article is for educational purposes based on ADA 2024, RSSDI and ICMR guidelines. HbA1c targets must be individualised. Diabetes diagnosis and management decisions must be made by a qualified physician with full clinical assessment.

Built by an MBBS, AFIH Certified Physician in Punjab, India | RxMedCalc.com